X連鎖性無ガンマグロブリン血症に対する新規遺伝子治療法の開発と安全性評価の検討

• Project/Area Number: 22K07917
• Research Category: Grant-in-Aid for Scientific Research (C)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 52050:Embryonic medicine and pediatrics-related
• Research Institution: Kyushu University
• Principal Investigator: 山元 裕之 九州大学, 環境発達医学研究センター, 特任助教 (00710170)
• Project Period (FY): 2022-04-01 – 2025-03-31
• Project Status: Declined (Fiscal Year 2022)
• Budget Amount: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000); Fiscal Year 2024: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000); Fiscal Year 2023: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000); Fiscal Year 2022: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)